AXA Framlington American Growth Fund - R Accumulation

Category US Large-Cap Growth Equity

Last buy/sell price

1,505.00p

arrow-down-7.00p (-0.46%)

Fund Code

0350921

GB0003509212

Prices updated as at 09 May 2025

Prices in GBX

Investment objective

The aim of this Fund is to provide long-term capital growth over a period of 5 years or more. The Fund invests principally (meaning at least 80% of its assets) in large and medium-sized companies listed in the US. The Fund invests in shares of companies which the Manager believes are attractive investment opportunities, relative to their industry peers. The Manager selects shares based upon analysis of a company’s financial status, quality of its management, expected profitability and prospects for growth.

Important documents: Please ensure that you have read the Key Information Document/Technical Guide , Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

Annual performance (%)

Year	This fund	US Large-Cap Growth Equity
31 Mar 14 - 31 Mar 15	30.72	25.60
31 Mar 15 - 31 Mar 16	-5.95	0.25
31 Mar 16 - 31 Mar 17	31.18	31.38
31 Mar 17 - 31 Mar 18	6.05	5.61
31 Mar 18 - 31 Mar 19	21.88	18.07
31 Mar 19 - 31 Mar 20	3.91	2.54
31 Mar 20 - 31 Mar 21	45.67	45.03
31 Mar 21 - 31 Mar 22	20.25	10.73
31 Mar 22 - 31 Mar 23	-8.30	-2.67
31 Mar 23 - 31 Mar 24	27.76	31.02
31 Mar 24 - 31 Mar 25	0.75	0.42

Trailing returns (%)

Year	This fund	US Large-Cap Growth Equity
1 Day	-0.46	0.15
1 Month	12.99	7.19
3 Months	-13.26	-13.74
6 Months	-6.29	-7.22
1 Year	2.87	3.48
3 Years annualised	10.88	11.77
5 Years annualised	12.77	11.16

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.